Combined Immunodeficiency Due to ZAP70 Deficiency
Immunology
Prevalence
0.1 / 100K
0 drugs in development·0 companies·1 clinical trial
Frequently asked questions
How many clinical trials target Combined Immunodeficiency Due to ZAP70 Deficiency?
There are 1 clinical trial targeting Combined Immunodeficiency Due to ZAP70 Deficiency tracked by BioSniper.
What is the prevalence of Combined Immunodeficiency Due to ZAP70 Deficiency?
The estimated prevalence of Combined Immunodeficiency Due to ZAP70 Deficiency is approximately 0.1 per 100,000 population.
Deep-dive into Combined Immunodeficiency Due to ZAP70 Deficiency
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis